Meanwhile, previous studies have shown that the expression of NER protein (ERCC1, ERCC2) may be sensitive prognostic indicators of radiochemotherapy for locally advanced HNSCC (52–54). This evidence concerns the gene ERCC1 and head and neck squamous cell carcinoma.